Showing results (231-240 of 391) with videos related to

Sort By:
Pageof 40
FEMS Microbiology Letters|February 15, 1994
Induction of resistance to novobiocin in the novobiocin-producing organism Streptomyces niveusJ H Hoggarth, K E Cushing, J I Mitchell, et al.
The West Indian Medical Journal|November 15, 2000
Chronic relapsing pancreatitis in a child. Use of the Puestow procedure to achieve ductal drainageN D Duncan, A McDonald, M James, et al.
Biochimica Et Biophysica Acta|March 21, 1993
The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysinT I Mitchell, J J Jeffrey, R D Palmiter, et al.
Sleep Medicine|October 30, 2004
Hippocampal area metabolites relate to severity and cognitive function in obstructive sleep apneaDelwyn J Bartlett, Caroline Rae, Campbell H Thompson, et al.
Experimental Lung Research|February 8, 2000
Bronchial casts of human lungs using negative pressure injectionS F Perry, A M Purohit, S Boser, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 12, 1998
Determination of the 243 Cm/244 Cm ratio alpha spectrometry and spectral deconvolution in environmental samples exposed to discharges from the nuclear fuel cycleP I Mitchell, E Holm, L León Vintró, et al.
The Health Care Manager|July 31, 2012
Validation of the French and English versions of the Worklife Pulse SurveyGenevieve L Lavigne, Charles Sounan, Mélanie Lavoie-Tremblay, et al.
Healthcare Management Forum|January 8, 2021
The Quality Mental Health Care Network: A roadmap to improving quality mental healthcare in CanadaEmily J Follwell, Siri Chunduri, Claire Samuelson-Kiraly, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 25, 2011
Exenatide - pharmacokinetics, pharmacodynamics, safety and tolerability in patients ≥ 75 years of age with Type 2 diabetesH Linnebjerg, P A Kothare, M Seger, et al.
European Journal of Clinical Pharmacology|August 20, 2013
The effect of hepatic or renal impairment on the pharmacokinetics of edivoxetine, a selective norepinephrine transporter reuptake inhibitorWilliam Kielbasa, Eshetu Tesfaye, Debra Luffer-Atlas, et al.
Pageof 40